Menu
Over the past 25 years, TROG Cancer Research has recorded 220 publications in national and international journals. View our current list of publications below.
| TROG Number | Acronym | Tumour | Citation | Category | Month/Year published | Journal |
|---|---|---|---|---|---|---|
| NA | - | NA | Lamb DS, Spry NA, Gray AJ, Johnson AD, Alexander SR, Dally MJ. Accelerated fractionation radiotherapy for advanced head and neck cancer. Radiother Oncol. 1990 Jun; 18(2):107-16. | NA | 1/06/1990 | Radiotherapy and Oncology |
| NA | - | NA | Gill PG, Denham JW, Jamieson GG, Devitt PH, Yeoh E, Olweny C. Patterns of treatment failure and prognostic factors associated with the treatment of esophageal carcinoma with chemotherapy and radiotherapy either as sole treatment or followed by surgery. J Clin Oncol. 1992 Jul; 10(7):1037-43. | NA | 1/07/1992 | Journal of Clinical Oncology |
| NA | - | NA | Hamilton CS, Denham JW, Joseph DJ, et al. Treatment and planning decisions in non-small cell carcinoma of the lung: an Australasian pattern of practice study. J Clin Oncol. 1992 May; 4(3):141-47. | NA | 1/05/1992 | Journal of Clinical Oncology |
| NA | - | NA | Hamilton CS and Denham JW. Dose normalisation and specification: from woe to go. Australas Radiol. 1992 May; 36(2):137-41. | NA | 1/05/1992 | Australasian Radiology |
| NA | - | NA | Denham JW, Hamilton CS, Joseph DJ, et al. The use of simulator and CT information in the planning of radiotherapy for non-small cell lung carcinoma; an Australasian pattern of practice study. Lung Cancer. 1993 Feb; 8(5-6):275-84. | NA | 1/02/1993 | Lung Cancer |
| NA | - | NA | Atkinson CH, Hamilton CS, Wynne CJ. Radiotherapy planning for lung cancer: Can we do better? Australas Radiol. 1994 Nov; 38(4):303-04. | NA | 1/11/1994 | Australasian Radiology |
| 89.04 | - | Gastrointestinal | Denham JW. Oesophageal cancer - guarded optimism. Med J Aust. 1994 Jun; 160(11):669-70. | A | 1/06/1994 | Medical Journal of Australia |
| 89.04 | - | Gastrointestinal | Burmeister BH, Denham JW, O'Brien M, Jamieson GG, Gill PG, Devitt P et al. Combined modality therapy for esophageal carcinoma: preliminary results from a large Australasian multicentre study. Int J Radiat Oncol Biol Phys. 1995 Jul; 32(4):997-1006. | A | 1/07/1995 | International Journal of Radiation Oncology Biology Physics |
| 89.02 | - | Breast | Denham JW, Hamilton CS, Christie D, O'Brien M, Bonaventura A, Stewart JF et al. Simultaneous adjuvant radiation therapy and chemotherapy in high-risk breast cancer - toxicity and dose modification: a Trans-Tasman Radiation Oncology Group multi-institution study. Int J Radiat Oncol Biol Phys. 1995 Jan; 31(2): 305-13. | A | 1/01/1995 | International Journal of Radiation Oncology Biology Physics |
| 89.02 | - | Breast | Christie DRH, O'Brien MY, Christie JA, Kron T, Ferguson SA, Hamilton CS et al. A comparison of methods of cosmetic assessment in breast conservation treatment. Breast. 1996 Oct; 5(5):358-67. | A | 1/10/1996 | Breast |
| 89.04 | - | Gastrointestinal | Denham JW, Burmeister BH, Lamb DS, Spry NA, Joseph DJ, Hamilton CS et al. Factors influencing outcome following radio-chemotherapy for oesophageal cancer. Radiother Oncol. 1996 Jul; 40(1):31-43. | A | 1/07/1996 | Radiotherapy and Oncology |
| 89.03 & 91.01 | - | Head and Neck/Gastrointestinal | Denham JW, Walker QJ, Lamb DS, Hamilton CS, O'Brien PC, Spry NA et al. Mucosal regeneration during radiotherapy. Trans Tasman Radiation Oncology Group (TROG). Radiother Oncol. 1996 Nov; 41(2):109-18. | A | 1/11/1996 | Radiotherapy and Oncology |
| 89.04 | - | Gastrointestinal | MacKean J, Burmeister BH, Lamb DS, Denham JW. Concurrent chemo-radiation for oesophageal cancer - Factors influencing myelotoxicity. Australas Radiol. 1996 Nov; 40(4):424-29. | A | 1/11/1996 | Australasian Radiology |
| 92.01 | - | Lymphoma | O'Brien PC, Roos D, Liew K-H, Trotter G, Barton M, Walker Q et al. Preliminary results of combined Chemotherapy and radiotherapy for non-AIDS primary Central Nervous System lymphoma. Trans-Tasman Radiation Oncology Group (TROG). Med J Aust. 1996 Oct; 165(8):424-27. | A | 1/10/1996 | Medical Journal of Australia |
| 89.04 | - | Gastrointestinal | Denham J and on behalf of the Trans-Tasman Radiation Oncology Group (TROG). Response to L. R. Coia re factors influencing outcome following radio-chemotherapy for oesophageal cancer. Radiother Oncol. 1997 Jan; 42(1): 91-2. (Letter) | A | 1/01/1997 | Radiotherapy and Oncology |
| 95.02 | - | Symptom Management | OBrien PC, Franklin CI, Dear KBG, Hamilton CS, et al. A phase III double-blind randomised study of rectal sucralfate suspension in the prevention of acute radiation proctitis: Trans-Tasman Radiation Oncology Group (TROG). Radiother Oncol. 1997 Nov; 45(2):11723. | A | 1/11/1997 | Radiotherapy and Oncology |
| 89.04 | - | Gastrointestinal | Smithers BM, Devitt P, Jamieson GG, Bessell J, Gotley D, Gill PG et al. A combined modality approach to the management of oesophageal cancer. Eur J Surg. 1997 Jun; 23(3):219-23. | A | 1/06/1997 | European Journal of Surgery |
| 89.04 | - | Gastrointestinal | Burmeister BH, Smithers BM, Denham JW. Combined modality therapy for carcinoma of the oesophagus: current status and future directions. Med J Aust. 1997 Oct; 167(7):349-50. | A | 1/11/1997 | Medical Journal of Australia |
| 89.03 | - | Gastrointestinal | Lamb DS, Denham JW, Morum PE, Gray AJ. Long-term results of accelerated radiation treatment for advanced head and neck cancer. A Trans-Tasman Radiation Oncology Group (TROG) Phase II study. Radiother Oncol. 1998 Oct; 49(1):29-32. | A | 1/10/1998 | Radiotherapy and Oncology |
| 91.01 | - | Head and Neck | Hamilton CS, Walker Q, Poulsen M, Spry N, Lamb D, Denham JW and Steigler A. Quality Assurance Audit in an Australasian Phase III Trial of Accelerated Radiotherapy for Head and Neck Cancer (TROG 91. 01). Australas Radiol. 1999 May; 43(2):227-32. | A | 1/05/1999 | Australasian Radiology |
| 91.01 | - | Head and Neck | Denham JW, Peters LJ, Johansen J, Poulsen M, Lamb DS, Hindley A, O'Brien P, Spry NA, Penniment M, Krawitz H, Williamson S, Bear J, Tripcony L. Do acute mucosal reactions lead to consequential late reactions in patients with head and neck cancer? Radiother Oncol. 1999 Aug; 52(2):157-64. | A | 1/05/1999 | Radiotherapy and Oncology |
| 89.02 | - | Breast | Lamb D, Atkinson C, Joseph D, O'Brien P, Ackland S, Bonaventura A, et al. Simultaneous adjuvant radiotherapy and chemotherapy for stage I and II breast cancer. Australas Radiol. 1999 May; 43(2):220-26. | A | 1/05/1999 | Australasian Radiology |
| 91.01 | - | Head and Neck | Poulsen M, Denham JW, Spry N, Lamb D, Peters L, Williamson S and L Tripcony. Acute toxicity and cost analysis of a phase III randomized trial of accelerated and conventional radiotherapy for squamous carcinoma of the head and neck: a Trans-Tasman Radiation Oncology Group study. Acute toxicity analysis of a phase III randomised trial of accelerated. Australas Radiol. 1999 Nov; 43(4):487-94. | A | 1/11/1999 | Australasian Radiology |
| 96.02 | - | Gastrointestinal | Denham JW, Ackland SP, Burmeister B, Walpole E, Lamb DS, Dady P and Spry N. Causes for increased myelosuppression with increasing age in patients with esophageal cancer treated by chemo-radiation. Eur J Cancer. 1999 Jun; 35(6):921-27. | A | 1/06/1999 | European Journal of Cancer |
| 96.01 | - | Genitourinary | Steigler A, Mameghan H, Lamb D, Joseph D, Matthews J, Franklin I, Turner S, Spry N, Poulsen M, North J, Kovacev O and Denham J. A quality assurance audit: Phase III trial of maximal androgen deprivation in prostate cancer (TROG 96. 01). Australas Radiol. 2000 Feb; 44(1): 65-71. | A | 1/02/2000 | Australasian Radiology |
| 96.05 | - | Symptom Management | Roos DE, Davis SR, O'Brien PC, Hoskin PJ, Spry NA, Burmeister BH, Turner S and Bernshaw D. Eligibility audits for the randomised neuropathic bone pain trial (Trans-Tasman Radiation Oncology Group Study, TROG 96. 05). Australas Radiol. 2000 Aug; 44(3):303-07. | A | 1/08/2000 | Australasian Radiology |
| 96.05 | - | Symptom Management | Roos DE, O'Brien PC, Smith JG, Spry NA, Hoskin PJ, Burmeister BH, Turner S and Bernshaw D. A role for radiotherapy in neuropathic bone pain: preliminary response rates from a prospective trial (Trans-Tasman Radiation Oncology Group, TROG 96. 05). Int J Radiat Oncol Biol Phys. 2000 Mar; 46(4): 975-81. | A | 1/03/2000 | International Journal of Radiation Oncology Biology Physics |
| 92.01 | - | Lymphoma | O'Brien P, Roos D, Pratt G, Liew K, Barton M, Poulsen M, Olver I and Trotter G. Phase II multicenter study of brief single-agent methotrexate followed by irradiation in primary CNS lymphoma. J Clin Oncol. 2000 Feb; 18(3):519-26. | A | 1/02/2000 | Journal of Clinical Oncology |
| 91.01 | - | Head and Neck | Poulsen M, Denham J, Peters L, Lamb D, Spry NA, Hindley A, Krawitz, H Hamilton C, Keller J, Tripcony L, Walker Q. A randomised trial of accelerated and conventional radiotherapy for stage III and IV squamous carcinoma of the head and neck: A Trans-Tasman Radiation Oncology Group Study (TROG 91.01). Radiother Oncol. 2001 Aug; 60(2):113-22. | A | 1/08/2001 | Radiotherapy and Oncology |
| 98.01 | - | Gastrointestinal | Ngan SYK, Burmeister BH, Fisher R, Rischin D, Schache DJ, Kneebone A, MacKay JR, Joseph D, Bell A and Goldstein D. Early toxicity from preoperative radiotherapy with continuous infusion 5-fluorouracil for resectable adenocarcinoma of rectum. A phase II trial for the Trans-Tasman Radiation Oncology Group. Int J Radiat Oncol Biol Phys. 2001 Jul; 50(4):883-87. | A | 1/07/2001 | International Journal of Radiation Oncology Biology Physics |
| 96.07 | - | Skin | Poulsen M, Rischin D, Walpole E, Harvey J, Macintosh J, Ainslie J, Hamilton C, Keller J Tripcony L. Analysis of toxicity of Merkel Cell Carcinoma of the skin treated with synchronous carboplatin/etopside and radiation: A Trans-Tasman Radiation Oncology Group study - TROG 96. 07. Int J Radiat Oncol Biol Phys. 2001 Sep; 51(1):156-63. | A | 1/09/2011 | International Journal of Radiation Oncology Biology Physics |
| 91.01 | - | Head and Neck | Denham JW and Kron T. Extinction of the weakest. Int J Radiat Oncol Biol Phys. 2001 Nov; 51(3): 80719. | A | 1/11/2001 | International Journal of Radiation Oncology Biology Physics |
| 96.06 | - | Skin | Burmeister BH, Smithers BM, Davis S, Spry N, Johnson C Krawitz H, Baumann KC. Radiation therapy following nodal surgery for melanoma: An analysis of toxicity. ANZ J Surg. 2002 May; 72(5):34448. | A | 1/05/2002 | ANZ Journal of Surgery |
| 96.01 & 91.01 | - | Genitourinary/Head and Neck | Kron T, Hamilton C, Roff M, Denham JW. Dosimetric intercomparison for two Australasian clinical trials using an anthropomorphic phantom. Int J Radiat Oncol Biol Phys. 2002 Feb; 52(2):56679. | A | 1/02/2002 | International Journal of Radiation Oncology Biology Physics |
| 95.02 | - | Symptom Management | O'Brien PC, Franklin CI, Joseph DJ, Spry NS, Denham JW. Acute symptoms, not rectally administered Sucralfate, predict for late radiation proctitis. Longer-term follow-up of a Phase 3 trial Trans-Tasman Radiation Oncology Group (TROG). Int J Radiat Oncol Biol Phys. 2002 Oct; 54(2):44249. | A | 1/02/2002 | International Journal of Radiation Oncology Biology Physics |
| 96.02 + 89.04 | - | Gastrointestinal | Denham JW, Steigler A, Kilmurray J, Wratten C, Burmeister B, Lamb DS, Joseph D Delaney G, Christie D, Jamieson G, Smithers BM, Ackland S, Walpole E. Relapse patterns after chemo-radiation for carcinoma of the oesophagus. J Clin Oncol. 2003 May; 15(3): 98108. | A | 1/05/2003 | Journal of Clinical Oncology |
| 96.05 | - | Symptom Management | Roos DE, Davis SR, Turner SL, OBrien PC, Spry NA, Burmeister BH, Hoskin PJ and Ball DL. Quality assurance experience with the randomised neuropathic bone pain trial (Trans-Tasman Radiation Oncology Group, 96.05). Radiother Oncol. 2003 May; 67(2):20712. | A | 1/05/2003 | Radiotherapy and Oncology |
| 91.01 | - | Head and Neck | Daly T, Poulsen GM, Denham JW, Peters LJ, Lamb DS, Krawitz H, Hamilton C, Keller J, Tripcony L, Walker Q. The effect of anaemia on efficacy and normal tissue toxicity following radiotherapy for locally advanced squamous cell carcinoma of the head and neck. Radiother Oncol. 2003 Aug; 68(2): 11322. | A | 1/08/2003 | Radiotherapy and Oncology |
| 96.01 | - | Genitourinary | Lamb DS, Denham JW, Mameghan H, Joseph D, Turner S, Matthews J, Franklin I, Atkinson C, North J, Poulsen M, Kovacev O, Robertson R, Francis L, Christie D, Spry NA, Tai KH, Wynne C, Duchesne G. Acceptability of short term neo-adjuvant androgen deprivation in patients with locally advanced prostate cancer. Radiother Oncol. 2003 Sep; 68(3):25567. | A | 1/09/2003 | Radiotherapy and Oncology |
| 98.04 | - | Symptom Management | Bydder S, Spry NA, Christie DRH, Roos D, Burmeister BH, Krawitz H, Davis S, Joseph DJ, Poulsen M, Berry M. A prospective trial of short-fractionation radiotherapy for the palliation of liver metastases. Australas Radiol. 2003 Sep; 47(3):28488. | A | 1/09/2003 | Australasian Radiology |
| 96.07 | - | Skin | Poulsen M, Rischin D, Walpole E, Harvey J, Mackintosh J, Ainslie J, Hamilton C, Keller J, Tripcony L. High-Risk Merkel Cell Carcinoma of the Skin Treated With Synchronous Carboplatin/Etoposide and Radiation: A Trans-Tasman Radiation Oncology Group StudyTROG 96:07. J Clin Oncol. 2003 Dec; 21(23): 4371-76. | A | 1/12/2003 | Journal of Clinical Oncology |
| - | - | NA | Christie D, Sharpley C, Curtis T. Improving the Accuracy of a Photographic Assessment System for Breast Cosmesis. J Clin Oncol. 2005 Feb; 17(1):27-31. | NA | 1/02/2005 | Journal of Clinical Oncology |
| 96.05 | - | Symptom Management | Roos D, Turner S, O'Brien P, Smith J, Spry N, Burmeister B, Hoskin P, Ball D. Randomized trial of 8Gy in 1 versus 20Gy in 5 fractions of radiotherapy for neuropathic pain due to bone metastases (Trans-Tasman Radiation Oncology Group, TROG 96.05). Radiother Oncol. 2005 Apr; 75(1):54-63. | A | 1/04/2005 | Radiotherapy and Oncology |
| 98.02 | - | Head and Neck | Rischin D, Peters L, Fisher R, Macann A, Denham J, Poulsen M, Jackson M, Kenny L, Penniment M, Corry J, Lamb D, McClure B. Tirapazamine, Cisplatin, and Radiation Versus Fluorouracil, Cisplatin, and Radiation in Patients With Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial of the Trans Tasman Radiation Oncology Group (TROG 98.02). J Clin Oncol. 2005 Jan; 23(1):79-87. | A | 1/01/2005 | Journal of Clinical Oncology |
| 94.01 | - | Gastrointestinal | Burmeister BH, Smithers BM, Gebski V, Fitzgerald L, Simes RJ, Devitt P, Ackland S, Gotley DC, Joseph D, Millar J, North J, Walpole ET, Denham JW. Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial. Lancet Oncol. 2005 Sep; 6(9):659-68. | A | 1/09/2005 | Lancet Oncology |
| 96.05 | - | Symptom Management | Pollicino CA, Turner SL, Roos DE, OBrien PC. Costing the components of pain management. Analysis of Trans-Tasman Radiation Oncology Group trial (TROG 96.05): One versus five fractions for neuropathic bone pain. Radiother Oncol. 2005 Sep; 76(3):26469. | A | 1/03/2005 | Radiotherapy and Oncology |
| 96.01 | - | Genitourinary | Christie D, Denham J, Steigler A, Lamb D, Turner S, Mameghan H, Joseph D, Matthews J, Franklin I, Atkinson C, North J, Poulsen M, Spry N, Tai K, Wynne C, Duchesne G, Kovacev O, Francis L, Kramar A, DEste C, Bill D. Delayed rectal and urinary symptomatology in patients treated for prostate cancer by radiotherapy with or without short term neo-adjuvant androgen deprivation. Radiother Oncol. 2005 Nov; 77(2):117-25. | A | 1/11/2005 | Radiotherapy and Oncology |
| 96.01 | - | Genitourinary | Denham JW, Steigler A, Lamb DS, Joseph D, Mameghan H, Turner S, Matthews J, Franklin I, Atkinson C, North J, Poulsen M, Christie D, Spry NA, Tai K-H, Wynne C, Duchesne G, Kovacev O, DEste C. Short-term androgen deprivation and radiotherapy for locally advanced prostate cancer: results from the Trans-Tasman Radiation Oncology Group 96.01 randomised controlled trial. Lancet Oncol. 2005; 6(11):841-50 | A | xx/xx/2005 | Lancet Oncology |
| 98.01 | - | Gastrointestinal | Ngan SYK, Fisher R, Burmeister BH, Mackay J, Goldstein D, Kneebone A, Schache D, Joseph D, McKendrick J, Leong T, McClure B, Rischin D. Promising results of a co-operative group phase II trials of preoperative chemoradiation for locally advanced rectal cancer (TROG 9801). Dis Colon Rectum. 2005 Jul; 48(7):1389-96. | A | 1/07/2005 | Diseases of the Colon and Rectum |
| 3.06 | TOAD | Genitourinary | Duchesne, GM, Syme R, Howell D. How early is early: Androgen deprivation for prostate-specific antigen relapse in prostate cancer. J Clin Oncol. 2006 June; 24(18):2964-64. | A | 1/06/2006 | Journal of Clinical Oncology |
| 1.05 | - | Symptom Management | Graham PH, Capp A, Delaney G, Goozee G, Hickey B, Turner S, Browne L, Milross C, Wirth A. A pilot randomised comparison of Dexamethasone 96 mg versus 16mg per day for malignant spinal-cord compression treated by radiotherapy: TROG 01.05 Superdex Study. J Clin Oncol. 2006 Feb; 18(1):70-6. | A | 1/02/2006 | Journal of Clinical Oncology |
| 96.07 | - | Skin | Poulsen M, Rischin D, Porter I, Walpole E, Harvey J, Hamilton C, Keller J, Tripcony L. Does Chemotherapy improve survival in high risk stage I and II Merkel Cell Carcinoma of the skin? Int J Radiat Oncol Biol Phys. 2006 Jan; 64(1):114-19. | A | 1/01/2006 | International Journal of Radiation Oncology Biology Physics |
| 92.01 | - | Lymphoma | OBrien PC, Roos DE, Pratt G, Liew K-H, Barton MB, Poulsen MG, Olver IA, Trotter GE. Combined-modality Therapy for Primary Central Nervous System Lymphoma: Long-term Data from a Phase II Multi-center Study (Trans-Tasman Radiation Oncology Group). Int J Radiat Oncol Biol Phys. 2006 Feb; 64(2):408-13. | A | 1/02/2006 | International Journal of Radiation Oncology Biology Physics |
| 3.08 | - | Symptom Management | Chow E, Hoskin P, Wu J, Roos D, van der Linden Y, Hartsell W, Vieth R, Wilson C, Pater J. A Phase III International Randomised Trial Comparing Single with Multiple Fractions for Re-irradiation of Painful Bone Metastases: National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) SC 20. J Clin Oncol. 2006 Mar; 18 (2):125-128. (Editorial) | B | 1/03/2006 | Journal of Clinical Oncology |
| - | - | NA | Chen Y, Trotti A, Coleman CN, Machtay M, Mirimanoff RO, Hay J, OBrien PC, El-Gueddari B, Salvajoli JV, Jeremic B. Adverse Event Reporting And Developments In Radiation Biology After Normal Tissue Injury: International Atomic Energy Agency Consultation. Int J Radiat Oncol Biol Phys. 2006 Apr; 64(5):144251. | NA | 1/04/2006 | International Journal of Radiation Oncology Biology Physics |
| 98.02 | - | Head and Neck | Rischin D, Hicks RJ, Fisher R, Binns D, Corry J, Porceddu S and Peters LJ. Prognostic significance of [F-18]-misonidazole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine: A substudy of Trans-Tasman Radiation Oncology Group study 98.02. J Clin Oncol. 2006 May; 24(13):2098-04. | A | 1/05/2006 | Journal of Clinical Oncology |
| 99.05 | - | Lung | Ball DL, Fisher R, Burmeister B, Graham P, Joseph D, Penniment M, Krawitz H, Wheeler G, Poulsen M, Vinod S and McClure B. Stage is not a reliable indicator of tumor volume in non-small cell lung cancer: a preliminary analysis of the Trans-Tasman Radiation Oncology Group 99-05 database. J Thorac Oncol. 2006 Sep; 1(7):667-72. | A | 1/09/2006 | Journal of Thoracic Oncology |
| 98.05 | - | Central Nervous System | Roos D, Wirth A, Burmeister B, Spry N, Drummond K, Beresford J and McClure B. Whole brain irradiation following surgery or radiosurgery for solitary brain metastases: Mature results of a prematurely closed randomized Trans-Tasman Radiation Oncology Group trial (TROG 98.05). Radiother Oncol. 2006 Sep; 80(3):318-22. | A | 1/09/2006 | Radiotherapy and Oncology |
| 99.06 + 97.01 | - |